Ran Reshef

9.4k citations
205 papers · 6.8k · 4 hit papers · h-index 39

Impact in

  • Hematology top 0.2%
    • Hematopoietic Stem Cell Transplantation
    • Acute Myeloid Leukemia Research
    • Multiple Myeloma Research and Treatments
  • Oncology top 2%
    • CAR-T cell therapy research
    • Viral-associated cancers and disorders
    • Cancer Immunotherapy and Biomarkers

Papers in

    • Hematopoietic Stem Cell Transplantation 101
    • Multiple Myeloma Research and Treatments 13
    • Acute Myeloid Leukemia Research 5
    • CAR-T cell therapy research 49
    • Viral-associated cancers and disorders 22

Ran Reshef

190 papers receiving 6.7k citations

Ran Reshef's Hit Papers

Safety and efficacy of standard-of-care ciltacabtagene autoleucel for relapsed/refractory multiple myeloma 2024 · 93 citations
930+3+7Years since publication200400600

Peers

Ran Reshef
Comparison fields: 5 of 94
  • Hematology 3.9k
  • Oncology 1.6k
  • Transplantation 88
  • Pathology and Forensic Medicine 372
  • Immunology 371
Replace Arnaud Jaccard with:
Arnaud Jaccard France
Yasushi Onishi Japan
Gabriela Rondón United States
Heiwa Kanamori Japan
Martin Gramatzki Germany
Carol Ann Huff United States
Claudio G. Brunstein United States
Matthias Stelljes Germany
Tatsuo Ichinohe Japan
Masahiro Imamura Japan
Ran Reshef relative to Arnaud Jaccard France Arnaud Jaccard's profile →
Citations per field
00.5×1.5×1.9×
Arnaud Jaccard · 1×
Citations per year

Countries citing papers authored by Ran Reshef

Since Specialization
Citations

This map shows the geographic impact of Ran Reshef's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ran Reshef with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ran Reshef more than expected).

Fields of papers citing papers by Ran Reshef

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ran Reshef. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ran Reshef. The network helps show where Ran Reshef may publish in the future.

Co-authors

The 25 scholars most cited alongside Ran Reshef, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ran Reshef Line = papers co-authored together Ran Reshef links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 205 papers — load more, or switch the sort, to bring in the rest.

#Work
1
International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium
Hit paper breakdown →
2015719
2
Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial
Hit paper breakdown →
2021515
3
Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis
Hit paper breakdown →
2023400
4 2016277
5 2017260
6 2019231
7 2012213
8 2017183
9 2011181
10 2018169
11 2018165
12 2015138
13 2021134
14 2023113
15 2017108
16
Safety and efficacy of standard-of-care ciltacabtagene autoleucel for relapsed/refractory multiple myeloma
Hit paper breakdown →
202493
17 201987
18 202084
19 201875
20 202067

About Ran Reshef

Ran Reshef is a scholar working on Hematology, Oncology, Immunology, Genetics and Physiology, having authored 205 papers that have together received 6.8k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (101 papers), CAR-T cell therapy research (49 papers), Viral-associated cancers and disorders (22 papers), Multiple Myeloma Research and Treatments (13 papers), T-cell and B-cell Immunology (7 papers), Nitric Oxide and Endothelin Effects (5 papers), Acute Myeloid Leukemia Research (5 papers) and Immunotherapy and Immune Responses (4 papers). The work is most often cited by research in Hematology (3.9k citations), Oncology (1.6k citations), Transplantation (88 citations), Pathology and Forensic Medicine (372 citations) and Immunology (371 citations). Ran Reshef has collaborated with scholars based in United States, Germany and France. Frequent co-authors include David Porter, Edward Allen Stadtmauer, Daniel F. Heitjan, Robert H. Vonderheide, Elizabeth Olson Hexner, Donald Edward Tsai, Marlise Rachael Luskin, Noelle V. Frey, Alison Wakoff Loren and Selina M. Luger. Their work appears in journals such as Transplantation and Cellular Therapy, Blood, Blood Advances, Journal of Clinical Oncology and Bone Marrow Transplantation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact